Source: Liu, P., et al. Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation. J. Vis. Exp. (2017).
This video demonstrates an assay to detect anti-donor HLA alloantibodies in organ recipients. A peptide array is synthesized to represent potential epitopes for antibody-mediated organ rejection. The array is incubated with the recipient's serum, containing alloantibodies that bind to their target epitopes. Antibody binding is detected using chemiluminescence to identify donor-specific HLA epitopes that incite alloantibody reactivity.
All procedures involving sample collection have been performed in accordance with the institute's IRB guidelines.
1. Design of Custom Array Layout and Production
2. Probe and Reprobe Antisera from a Time Series of an Individual Transplant Recipient.
NOTE: The 600-spot membrane array has the dimensions ~7 cm x 13 cm. After synthesis, the arrays can be stored at room temperature as dry membranes for at least two years when shielded from direct light. Avoid excessive folding of the membrane to preserve its longevity for repeated use.
3. Compare Antiserum Reactivity across a Clinical Time Series.
Figure 1. Image of an array section stained with Ponceau S
Note disparity in color intensity is due to differences in amino acid composition among peptides, while peptide concentrations among all spot areas are the same. (The image is an illustrative example, not the one from this actual study.)
Figure 2. Donor-specific HLA-A, B, C, DQ, DR array study of mismatched epitopes in PTN#4.
Serial peptides were derived from the donor's sequences to cover mismatched residues (An example of DQB1 in Figure 3). The array was used to probe the post-transplant serum (lower blot: post-TX) and, subsequently, the pre-transplant serum (upper blot: pre-TX) from the same patient. The four sets of strong spots from post-transplant probing are marked by red lines (in the lower blot), while two medium-intensity spots that were only associated with pre-transplant serum are marked by blue lines (in the upper blot). The bottom table shows the corresponding peptide sequences and their reactivity to the post-transplant serum. Donor-specific (mismatched) residues E87, I306, W243 and K197 of their respective alleles are in red letters, and peptides showing strong antibody reactivity are in bold fonts. This figure was adapted and modified by Liu et al.
Figure 3. Comparison of donor vs. patient/recipient HLA DQB1 and selection of template sequences for peptide synthesis.
The donor's sequences are in bold, with donor-specific mismatches in red font and also highlighted with black boxes. Template sequences (underlined) for deriving peptides contain these donor-specific residues. (This figure was adapted and modified from Liu et al.)
The authors have nothing to disclose.
Peptide array | INTAVIS Bioanalytical Instruments | ||
Ethanol | Sigma-Aldrich | E7023 | |
Ponceau S solution | Sigma-Aldrich | P7170 | |
Non-fat milk | Bio Rad Laboratories | 1706404 | |
TBST | Santa Cruz Biotechnology | 10711454001 | |
Goat anti-human IgG–HRP | ThermoFisher Scientific | A18811 | |
Clarity Western ECL Substrate | Bio Rad Laboratories | 1705061 | |
Restore Western Blot Stripping Buffer | Thermo Scientifics | 21059 | |
ChemiDoc gel imaging system | Bio Rad Laboratories | 1708265 |